Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Citi
Farmers Insurance
McKinsey
Cerilliant
Boehringer Ingelheim
US Department of Justice
QuintilesIMS
Chubb
Daiichi Sankyo

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,430,057

« Back to Dashboard

Summary for Patent: 5,430,057
Title: Parenteral busulfan for treatment of malignant disease
Abstract:Stable parenteral formulations of busulfan safe for parenteral administration are disclosed that exhibit improved bioavailability and optimize high dose busulfan therapy against malignant disease.
Inventor(s): Andersson; Borje S. (Houston, TX), Bhagwatwar; Harshal P. (Houston, TX), Chow; Diana S. L. (Houston, TX)
Assignee: Board of Regents, The University of Texas System (Austin, TX) University of Houston-University Park (Houston, TX)
Application Number:08/129,995
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use; Composition;

Drugs Protected by US Patent 5,430,057

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,430,057

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 197670 ➤ Sign Up
Australia 694141 ➤ Sign Up
Australia 7829094 ➤ Sign Up
Canada 2171738 ➤ Sign Up
Germany 69426334 ➤ Sign Up
Denmark 0725637 ➤ Sign Up
European Patent Office 0725637 ➤ Sign Up
Spain 2153862 ➤ Sign Up
Greece 3035447 ➤ Sign Up
Japan 3599285 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Fish and Richardson
AstraZeneca
Johnson and Johnson
McKinsey
Queensland Health
Chinese Patent Office
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot